Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | HRH2 | P25021 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL413401 | 0.88 | SRD5A1 (0.47) | SRD5A1SLC6A4ACHEHTR2CHTR2A | |
| SCHEMBL30298331 | 0.88 | SRD5A1 (0.47) | SRD5A1SLC6A4ACHEHTR2CHTR2A | |
| SCHEMBL8900410 | 0.85 | ACHE (0.41) | LMNASLC6A4ACHEHTR2CHTR2A | |
| SCHEMBL12410189 | 0.79 | UGT2B17 (0.51) | SRD5A1LMNAMEN1KMT2AESR1 | |
| SCHEMBL10069514 | 0.79 | ACHE (0.41) | SRD5A1LMNASLC6A4ACHEALDH1A1 | |
| SCHEMBL12352398 | 0.79 | ACHE (0.41) | SRD5A1LMNASLC6A4ACHEALDH1A1 | |
| SCHEMBL12352440 | 0.79 | ACHE (0.41) | SRD5A1LMNASLC6A4ACHEALDH1A1 | |
| SCHEMBL21870100 | 0.79 | UGT2B17 (0.51) | SRD5A1LMNAMEN1KMT2AESR1 | |
| SCHEMBL23315623 | 0.79 | HTR2C (0.36) | HTR2CHTR2AHTR2BESR1ESR2 | |
| SCHEMBL16257828 | 0.79 | SRD5A1 (0.43) | SRD5A1HTR2CHTR2AHTR2BESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220152587-A1 | JUTE STEM-SUPPORTED PALLADIUM-NPS AND USE AS DIP-CATALYSTS FOR AQUEOUS TRANSFER HYDROGENATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-05-19 | — | — | US | claimed |
| EP-0582108-B1 | Process for production of dimethyltetralin | MITSUBISHI GAS CHEMICAL CO (JP) | 1996-10-09 | — | — | EP | claimed |
| US-5396007-A | Dehydrogenating dimethyltetrahydronaphthalene in diluted medium using palladium or platinum catalyst supported by activated carbon | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1995-03-07 | — | — | US | claimed |
| US-5396008-A | Cyclization | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 1995-03-07 | — | — | US | claimed |
| EP-0582108-A1 | Process for production of dimethyltetralin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1994-02-09 | — | — | EP | claimed |
| US-5189234-A | Dimethyltetralin to dimethylnaphthalene | AMOCO CORPORATION (US) | 1993-02-23 | — | — | US | claimed |
| US-11446636-B2 | Jute stem-supported palladium-NPS and use as dip-catalysts for aqueous transfer hydrogenation | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-09-20 | — | — | US | disclosed |
| US-20220152587-A1 | JUTE STEM-SUPPORTED PALLADIUM-NPS AND USE AS DIP-CATALYSTS FOR AQUEOUS TRANSFER HYDROGENATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-05-19 | — | — | US | disclosed |
| EP-3103789-B1 | METHOD FOR PRODUCING (R)-1,1,3-TRIMETHYL-4-AMINOINDANE | SUMITOMO CHEMICAL CO (JP) | 2018-10-31 | — | — | EP | disclosed |
| EP-2915801-B1 | PRODUCTION METHOD FOR RACEMATE OF COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-07-04 | — | — | EP | disclosed |
| US-9765032-B2 | Method for producing (R)-1,1,3-trimethyl-4-aminoindane | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-09-19 | — | — | US | disclosed |
| US-20170166532-A1 | METHOD FOR PRODUCING (R)-1,1,3-TRIMETHYL-4-AMINOINDANE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-15 | — | — | US | disclosed |
| EP-3103789-A1 | METHOD FOR PRODUCING (R)-1,1,3-TRIMETHYL-4-AMINOINDANE | Sumitomo Chemical Company Limited (JP) | 2016-12-14 | — | — | EP | disclosed |
| EP-0687248-B1 | CRYSTALLIZATION OF 2,6-DIMETHYLNAPHTHALENE | AMOCO CORP (US) | 1999-10-20 | — | — | EP | disclosed |
| EP-0926114-A2 | Crystallization of 2,6-Dimethylnaphthalene | AMOCO CORPORATION (US) | 1999-06-30 | — | — | EP | disclosed |
| US-5510563-A | ALKENYLATION, CYCLIZATION, DEHYDROGENATION, AND ISOMERIZATION | AMOCO CORPORATION (US) | 1996-04-23 | — | — | US | disclosed |
| US-5365001-A | Catalytic cyclization of alkenebenzene in the presence of hydrogen | TEIJIN LIMITED (JP) | 1994-11-15 | — | — | US | disclosed |
| EP-0594856-A1 | PROCESS FOR PRODUCING DIALKYLNAPHTHALENE | TEIJIN LIMITED (JP) | 1994-05-04 | — | — | EP | disclosed |
| US-4382851-A | HYDROGEN SULFIDE, CARBON MONOXIDE, AROMATIC HYDROCARBONS | MOBIL OIL CORPORATION (US) | 1983-05-10 | — | — | US | disclosed |
| US-3997616-A | FROM ALKENYLBENZENE, CYCLIZATION CATALYST | TEIJIN LIMITED (JA) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166532-A1 | METHOD FOR PRODUCING (R)-1,1,3-TRIMETHYL-4-AMINOINDANE | HTR1D, TPH1, HTR1A | SRD5A1 67/4885LMNA 2501/4885SLC6A4 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.